What are the DSM‑5 criteria for amphetamine or other stimulant withdrawal in individuals who do not meet criteria for a stimulant use disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DSM-5 Criteria for Amphetamine or Other Stimulant Withdrawal (Without Use Disorder)

Amphetamine or other stimulant withdrawal can be diagnosed in DSM-5 even in individuals who do not meet criteria for a stimulant use disorder, as withdrawal is a distinct substance-induced disorder that stands independently from the use disorder diagnosis 1.

Core Diagnostic Framework

The DSM-5 conceptualizes substance-induced disorders (including withdrawal) as separate diagnostic entities that do not require the presence of a substance use disorder 1. This represents a critical distinction: withdrawal syndromes are diagnosed based on their own specific criteria, not on whether someone meets the threshold for use disorder.

Key Diagnostic Principles

For stimulant withdrawal to be diagnosed, the condition must:

  • Resemble the full criteria for the relevant withdrawal syndrome - This is a fundamental DSM-5 requirement for substance-induced disorders 1
  • Occur following cessation or reduction of prolonged amphetamine or other stimulant use - The temporal relationship is essential
  • Be pharmacologically capable of producing the withdrawal symptoms - The substance must have the biological capacity to cause these effects 1
  • Cause clinically significant distress or impairment - The symptoms must be meaningful enough to warrant clinical attention

Specific Withdrawal Symptoms

Based on the DSM-5 framework for stimulant withdrawal, the diagnosis requires:

A. Cessation of (or reduction in) amphetamine or other stimulant use that has been heavy and prolonged

B. Dysphoric mood and two or more of the following physiological changes developing within hours to several days:

  • Fatigue
  • Vivid, unpleasant dreams
  • Insomnia or hypersomnia
  • Increased appetite
  • Psychomotor retardation or agitation

C. The symptoms cause clinically significant distress or impairment in functioning

D. The symptoms are not attributable to another medical condition or better explained by another mental disorder

Critical Clinical Distinctions

Withdrawal vs. Use Disorder Independence

The DSM-5 explicitly removed the requirement that symptoms must "exceed expected intoxication or withdrawal symptoms" 1. This change means that withdrawal can be diagnosed on its own merits, regardless of whether the person meets criteria for stimulant use disorder (which requires 2 or more of 11 criteria including impaired control, social impairment, risky use, and pharmacological indicators like tolerance) 1.

Timeline Considerations

DSM-5 substance-induced disorders are expected to remit within days to weeks of abstinence 1. For stimulant withdrawal specifically, symptoms typically develop within hours to several days after cessation and resolve within days to weeks 1.

Common Clinical Pitfalls

Do not confuse withdrawal with:

  • Craving alone - While craving is a DSM-5 use disorder criterion that can persist long into remission 1, withdrawal is an acute syndrome with specific physiological and mood symptoms
  • Intoxication effects - The temporal relationship to cessation/reduction is key
  • Primary mood disorders - Rule out independent depressive or anxiety disorders that preceded stimulant use

Do not assume use disorder is required - This is perhaps the most important clinical point. Someone who used stimulants heavily (perhaps prescribed for ADHD, or recreational use without meeting 2+ use disorder criteria) can still experience clinically significant withdrawal 1.

Practical Application

In clinical practice, you might encounter this scenario with:

  • Patients prescribed stimulants for ADHD who abruptly discontinue without meeting use disorder criteria
  • Individuals who used stimulants heavily for a period but don't have the pattern of impaired control, social consequences, or risky use that defines use disorder
  • Patients in controlled environments (hospitalization, incarceration) where stimulant access is suddenly removed

The diagnosis hinges on: (1) documented heavy/prolonged use, (2) temporal relationship to cessation/reduction, (3) presence of dysphoric mood plus 2+ physiological changes, and (4) clinically significant distress or impairment - not on whether the person has a use disorder 1.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.